Form 4 for MRNA Moderna
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-27 · accession 0001127602-24-023134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-29 | 2024-08-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +2,652 | 18.6K | +17% | — |
| D | 2024-08-29 | 2024-08-28 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $79.39 | -1,319 | 17.3K | -7% | -$104.7K |
| D | 2024-08-29 | 2024-08-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -2,652 | 5,305 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-27 | M | A | 2,652 | — | 18,599 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-08-28 | S | D | 1,319 | $79.39 | 17,280 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-08-27 | M | D | 2,652 | $0.00 | 5,305 | D | — · — to — | 2,652 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. |